Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 2 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Sakata Seed Corporation has 6 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are handled by 5 distinct examiners across 2 distinct art units. This concentration in only 2 art units suggests that the company's patent applications are focused on a narrow range of technical subject matter within the biotech sector. The high number of actions relative to the number of art units indicates a dense prosecution environment.
ZHONG, WAYNESHAOBIN is the busiest examiner, with 2 pending office actions. The remaining pending actions are distributed among the other distinct examiners. Because 6 pending actions are being reviewed in only 2 distinct art units, there is a high density of applications per specialized group. This concentration may allow for more consistent prosecution strategies within those 2 specialized groups, even though 5 different examiners are involved. Practitioners should focus on the standards of these 2 distinct art units while managing the preferences of the 5 distinct examiners.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (33%) |
| §103 only | 1 (17%) |
| Double-patenting + other | 2 (33%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHONG, WAYNESHAOBIN | 2 | 72.3% | +21.4% |
| IBRAHIM, MEDINA AHMED | 1 | 87.4% | +12.2% |
| DELEO, VICTORIA LYNN | 1 | 41.4% | -44.4% |
| KINGDON, CATHY | 1 | 80.3% | +2.6% |
| BYRNES, DAVID R | 1 | 78.2% | +20.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19123805 | BROCCOLI PLANT THAT PRODUCES SMALL FLOWER BUDS WITH UNIFORM SIZE AND HIGH YIELD, AND METHOD FOR PRODUCING PROCESSED PRODUCT THEREOF | IBRAHIM, MEDINA AHMED | — |
| 18560069 | SPINACH PLANT HAVING NOVEL DOWNY MILDEW-RESISTANT GENE | DELEO, VICTORIA LYNN | — |
| 18037836 | CYTOPLASMIC MALE STERILE PLANT OF GENUS PETUNIA, INTERGENERIC HYBRID PLANT THEREOF, AND METHOD OF PRODUCING SAME | KINGDON, CATHY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18767320 | Inbred Broccoli line BP-1 | ZHONG, WAYNESHAOBIN | 19d overdue |
| 18767758 | Inbred Broccoli Line BP-2 | ZHONG, WAYNESHAOBIN | 18d overdue |
| 19123805 | BROCCOLI PLANT THAT PRODUCES SMALL FLOWER BUDS WITH UNIFORM SIZE AND HIGH YIELD, AND METHOD FOR PRODUCING PROCESSED PRODUCT THEREOF | IBRAHIM, MEDINA AHMED | — |
| 17604175 | CYTOPLASMIC MALE STERILE PLANT OF GENUS LACTUCA HAVING IMPROVED LOW TEMPERATURE GROWTH ABILITY | BYRNES, DAVID R | — |
| Art Unit | Apps |
|---|---|
| 1662 | 5 |
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19123805 | BROCCOLI PLANT THAT PRODUCES SMALL FLOWER BUDS WITH UNIFORM SIZE AND HIGH YIELD, AND METHOD FOR PRODUCING PROCESSED PRODUCT THEREOF | IBRAHIM, MEDINA AHMED | 1662 | §102§103§112 | Non-Final OA | — | Pending | Sep 15, 2025 |
| 18767320 | Inbred Broccoli line BP-1 | ZHONG, WAYNESHAOBIN | 1662 | §112DP | Final Rejection | 19d overdue | Pending | Jul 09, 2024 |
| 18767758 | Inbred Broccoli Line BP-2 | ZHONG, WAYNESHAOBIN | 1662 | §112DP | Final Rejection | 18d overdue | Pending | Jul 09, 2024 |
| 18560069 | SPINACH PLANT HAVING NOVEL DOWNY MILDEW-RESISTANT GENE | DELEO, VICTORIA LYNN | 1662 | §101§102§103§112 | Non-Final OA | — | Pending | Nov 09, 2023 |
| 18037836 | CYTOPLASMIC MALE STERILE PLANT OF GENUS PETUNIA, INTERGENERIC HYBRID PLANT THEREOF, AND METHOD OF PRODUCING SAME | KINGDON, CATHY | 1663 | §101§102§103§112 | Final Rejection | — | Pending | May 19, 2023 |
| 17604175 | CYTOPLASMIC MALE STERILE PLANT OF GENUS LACTUCA HAVING IMPROVED LOW TEMPERATURE GROWTH ABILITY | BYRNES, DAVID R | 1662 | §103 | Non-Final OA | — | Pending | Oct 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSakata Seed Corporation has 6 pending office actions as of October 2026, spread across 2 art units and 5 examiners.
Wayneshaobin Zhong has the most, with 2 of Sakata Seed Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
